Noom has launched GLP-1Rx, a weight loss program that combines prescription GLP-1 medications with behavioral coaching and digital tools. The program positions itself as a comprehensive approach to weight management rather than medication alone.
GLP-1 receptor agonists like semaglutide and tirzepatide work by mimicking a hormone that regulates appetite and blood sugar. These medications have gained widespread popularity for weight loss, but Noom's model emphasizes that medication works best alongside behavior change. The company pairs prescriptions with its existing app-based coaching system, which uses psychology-backed techniques to help users develop sustainable eating habits and lifestyle patterns.
The program offers customization based on individual health profiles and goals. Users work with healthcare providers through Noom's platform to receive medical oversight while also accessing behavioral support. This dual approach addresses a common concern with GLP-1 medications: that weight loss achieved through medication alone may reverse once people stop taking it. Studies show that combining medication with lifestyle intervention produces more durable results.
Noom's existing app helps users identify eating patterns and emotional drivers behind food choices. Adding GLP-1 medication to this framework means people get pharmaceutical support for appetite management while simultaneously learning new habits. The behavioral component addresses the psychological aspects of weight management that medication cannot touch.
The program costs more than GLP-1 prescriptions alone, but less than some standalone telehealth GLP-1 services that lack behavioral support. Users get access to Noom's coaches, food tracking tools, and educational content designed to reinforce behavior change.
This integration reflects a shift in how weight loss is being approached clinically. Rather than viewing medication and behavior change as separate strategies, integrated programs treat them as complementary. People using GLP-1 medications often experience reduced appetite, creating a window where building new eating habits becomes easier. Noom attempts to capitalize